innovative family of products have received 510(k) clearance from the U.S. Food & Drug Administration (FDA) to treat patients suffering from lymphedema and chronic venous insufficiency. The company's patient-focus has also led to the development of Comply Care, a comprehensive disease management and compliance program that helps ensure the best clinical outcome for patients while reducing overall cost-of-care.